Literature DB >> 10185526

Charge what you will ... reimbursements are shrinking.

M Crane.   

Abstract

Mesh：

Year:  1998        PMID： 10185526

Source DB:  PubMed          Journal:  Med Econ        ISSN： 0025-7206


× No keyword cloud information.
  2 in total

1.  Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma.

Authors:  R Menendez; R H Stanford; L Edwards; C Kalberg; K Rickard
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.

Authors:  Ketan Sheth; Rohit Borker; Amanda Emmett; Kathleen Rickard; Paul Dorinsky
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.